2021 was a very successful year for CRISPR in the medical field. Much of the success comes down to gene editing without double-strand breaks,...
In this piece, we provide selected highlights from the 63rd American Society of Hematology annual meeting, held from December 11-14th 2021.
Some of the best links we picked up around the internet
Update on Allogene Therapeutics off-the-shelf CAR-T cancer therapies. This week’s gene-editing update looks at an investigational new drug (IND)...
Last week, we bought you our first IND update for a selection of gene-editing therapies currently under development for blood disorders. This week, we...
During clinical development, science is turned into medicine. Data from basic research, pre-clinical pharmacology and safety studies are put to the...
